All I care about is seeing the gap between revenue and costs narrowing more and more. If our profitability projections hold up over the next few quarterlies this thing may actually turn around. All the tech stuff is nice but it's all blah blah blah. Close the revenue gap, regain confidence in solid management and we'll see the turn around.
- Forums
- ASX - By Stock
- No Calcification
All I care about is seeing the gap between revenue and costs...
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.00 |
Change
0.200(2.27%) |
Mkt cap ! $190.2M |
Open | High | Low | Value | Volume |
$8.90 | $9.48 | $8.88 | $176.7K | 19.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 590 | $8.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.40 | 70 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 590 | 8.800 |
2 | 2067 | 8.680 |
1 | 260 | 8.510 |
1 | 300 | 8.500 |
1 | 2 | 8.420 |
Price($) | Vol. | No. |
---|---|---|
9.400 | 70 | 1 |
9.430 | 105 | 1 |
9.490 | 218 | 1 |
9.500 | 250 | 1 |
9.850 | 1000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online